Black Children Face Higher Risks of Specific Asthma Type
New research shows a strong link between race and high-inflammation asthma profiles in school-aged children.
Updated on Oct. 30, 2026 in Asthma
Live Poll
Should medical researchers prioritize investigating biological factors over social factors to reduce health disparities?
New research identifies Black race and ethnicity as the primary predictor for high T-helper 2 inflammation in children diagnosed with severe, treatment-refractory asthma. This study provides insight into how biological profiles shift during childhood, reaching a peak prevalence of 70% in older children.
Why it matters
Understanding which children are most likely to express specific inflammatory phenotypes helps clinicians better tailor care for severe asthma. These findings clarify the link between demographic factors and biological markers to improve precision in pediatric respiratory management.
This cohort study of 451 children with treatment-refractory asthma found that Black race and ethnicity strongly predicted high T2 inflammation. Researchers observed that blood markers for this phenotype increased from 35% in children aged 2 to 70% in children aged 9 and 14.
The players
UVA Health Children's
A pediatric health system that provides specialized care for children with complex conditions including severe asthma.
The details
T-helper 2 inflammation is a specific immune response that researchers identified by measuring eosinophilia and allergen-specific IgE. The study used multivariable logistic regression and nonlinear neural network models to account for social, environmental, and clinical variables. By isolating these factors, the team determined that race acts as a significant predictor for these specific inflammatory profiles.
Timeline
October 2026: Study results were published.
Health Landscape
This research aligns with ongoing efforts by the National Institutes of Health to categorize asthma through biological phenotypes rather than just symptoms. It highlights a shift toward precision medicine in treating severe, treatment-refractory cases.
Parents of children with severe asthma should discuss their child's specific inflammatory markers, such as IgE levels or eosinophil counts, with their pediatrician. These conversations can help determine if a child's condition aligns with the T2HIGH phenotype and what that means for potential treatment plans.
The takeaway
Severe asthma is a complex condition that may evolve significantly as children grow. It is important to work with a specialist to track blood markers and identify the specific type of inflammation driving your child's symptoms to ensure the most effective, evidence-based care.
Further reading
For more information on managing chronic respiratory conditions, visit our Asthma section.
Source note: This article includes information reported by Healio.
Live Poll
Should medical researchers prioritize investigating biological factors over social factors to reduce health disparities?
